Avascular Necrosis Market Size In 2026: Regional Growth, Key Segments And Future Outlook
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Avascular Necrosis Market Value Growth And Long-Term Outlook
The avascular necrosis market has demonstrated robust growth in recent years. Looking ahead, it is projected to expand from $0.89 billion in 2025 to $0.97 billion in 2026, at a compound annual growth rate (CAGR) of 9.5%. The historical growth can be attributed to several factors including trauma-related bone injuries, steroid overuse, alcohol consumption, delayed diagnosis, and the overall growth in orthopedic surgery.
The avascular necrosis market size is set to experience substantial growth over the coming years. It is anticipated to reach $1.38 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This expansion during the forecast period is driven by factors such as the increasing adoption of advanced imaging, research in regenerative medicine, an aging demographic, the prevalence of sports injuries, and innovations in orthopedics. Significant trends expected in this period include the rising application of early diagnostic imaging, a greater acceptance of joint-preserving therapies, an increase in minimally invasive surgical procedures, the expansion of physical rehabilitation initiatives, and a dedicated focus on early-stage disease intervention.
Get A Free Sample Report With In-Depth Market Insights:
Avascular Necrosis Market Growth Factors: What’s Supporting Expansion?
An increasing volume of knee replacements and hip surgeries is anticipated to fuel the expansion of the avascular necrosis market moving forward. These surgical interventions involve replacing compromised joints and alleviating discomfort in advanced instances of avascular necrosis. The rise in these procedures stems from the rising occurrence of osteoarthritis, a condition leading to intense joint pain and mobility challenges, frequently necessitating surgical intervention for relief and enhanced life quality. Avascular necrosis plays a substantial role in the demand for knee and hip replacements, as this condition results in the death of bone tissue due to insufficient blood supply, often leading to joint decay and eventual collapse. For example, in November 2024, data from the American Joint Replacement Registry (AJRR), a US-based registry managed by the American Academy of Orthopaedic Surgeons, revealed that in 2023, over 4 million hip and knee arthroplasty procedures were recorded, signifying an 18% rise from 2022. Consequently, the increasing frequency of knee replacements and hip surgeries is propelling the growth of the avascular necrosis market. The increasing healthcare expenditure is anticipated to drive the expansion of the avascular necrosis market moving forward. Healthcare expenditure represents the total funds allocated to health services, treatments, and medical products within a given population or healthcare system. This spending is on the rise due to the growing prevalence of chronic illnesses, which necessitate ongoing management, frequent hospital visits, and expensive medications. For avascular necrosis, increased healthcare spending is beneficial as it facilitates access to prompt diagnosis, advanced therapeutic options, and surgical procedures that aid in managing the condition and enhancing patient outcomes. For example, in April 2025, the American Medical Association, a US-based professional association and lobbying group for physicians and medical students, reported that health spending in the United States climbed by 7.5% in 2023 to $4.9 trillion, or $14,570 per capita, which was a higher increase than the 4.6% observed in 2022. Consequently, the growth of the avascular necrosis market is being propelled by rising healthcare expenditure.
Avascular Necrosis Market Segment Analysis And Revenue Potential
The avascular necrosis market covered in this report is segmented –
1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis
2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray
3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting
4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings
Subsegments:
1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis
2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis
Avascular Necrosis Market Key Players Shaping Industry Direction
Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.
View The Full Avascular Necrosis Market Report:
Avascular Necrosis Market Top Region By Revenue And Market Share
North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
